Patent EP3690038A1: Antibody Pyrrolidobenzodiazepine Derivative Conjugate
Summary
The European Patent Office has published patent application EP3690038A1 for an "Antibody Pyrrolidobenzodiazepine Derivative Conjugate" filed by Daiichi Sankyo Company, Limited. This publication relates to a new class of therapeutic compounds.
What changed
The European Patent Office (EPO) has published patent application EP3690038A1, titled "Antibody Pyrrolidobenzodiazepine Derivative Conjugate." The application was filed by Daiichi Sankyo Company, Limited, and lists multiple inventors. This publication signifies the formal disclosure of the patent application, detailing the invention related to antibody-drug conjugates.
This patent publication is primarily an informational disclosure. For compliance officers in the pharmaceutical sector, it highlights ongoing innovation and potential future therapeutic developments. While this publication does not impose immediate compliance obligations, it is relevant for competitive intelligence and understanding the intellectual property landscape in oncology drug development. No specific compliance actions or deadlines are associated with this patent publication itself.
Source document (simplified)
ANTIBODY-PYRROLOBENZODIAZEPINE DERIVATIVE CONJUGATE
Publication EP3690038A1 Kind: A1 Mar 11, 2026
Applicants
Daiichi Sankyo Company, Limited
Inventors
TODA Narihiro, OTA Yusuke, DOI Fuminao, MEGURO Masaki, HAYAKAWA Ichiro, ASHIDA Shinji, MASUDA Takeshi, NAKADA Takashi, IWAMOTO Mitsuhiro, HARADA Naoya, TERAUCHI Tomoko, OKAJIMA Daisuke, NAKAMURA Kensuke, UCHIDA Hiroaki, HAMADA Hirofumi
IPC Classifications
A61K 31/5513 20060101AFI20260205BHEP A61K 39/395 20060101ALI20260205BHEP A61K 47/68 20170101ALI20260205BHEP A61P 35/00 20060101ALI20260205BHEP C07D 519/00 20060101ALI20260205BHEP C07K 16/1203 20260101ALI20260205BHEP C07K 16/18 20060101ALI20260205BHEP C07K 16/28 20060101ALI20260205BHEP C07K 16/32 20060101ALI20260205BHEP C07K 16/00 20060101ALI20260205BHEP C07K 16/30 20060101ALI20260205BHEP
Designated States
AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR
Named provisions
Related changes
Source
Classification
Who this affects
Taxonomy
Browse Categories
Get Pharma & Drug Safety alerts
Weekly digest. AI-summarized, no noise.
Free. Unsubscribe anytime.
Get alerts for this source
We'll email you when ChangeBridge: EPO Bulletin - Peptides (C07K) publishes new changes.